Page last updated: 2024-08-23

sufentanil and Substance Withdrawal Syndrome

sufentanil has been researched along with Substance Withdrawal Syndrome in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's5 (41.67)18.2507
2000's2 (16.67)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benahmed-Canat, A; Canat, G; Claris, O; Kassai, B; Nguyen, KA; Paret, N; Plaisant, F; Rabilloud, M; Riche, B1
Hronová, K; Pokorná, P; Posch, L; Slanař, O1
Freye, E; Levy, JV1
Chakrabarti, S; Gintzler, AR; Liu, NJ; Sharma, T; Zadina, JE1
Freye, EC; Korak-Leiter, M; Levy, JV; Likar, R; Oher, M; Trampitsch, E; Ziervogel, G1
Freye, E; Levy, J1
Adams, RE; Wooten, GF2
de Leon-Casasola, OA; Lema, MJ1
Fassos, FF; Mucha, RF; Walker, MJ1
Ayesta, FJ; Flórez, J1
Stevens, CW; Yaksh, TL1

Trials

1 trial(s) available for sufentanil and Substance Withdrawal Syndrome

ArticleYear
Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.
    Intensive care medicine, 2005, Volume: 31, Issue:3

    Topics: Adolescent; Adult; Aged; Analgesics, Opioid; beta-Endorphin; Blood Pressure; Conscious Sedation; Critical Care; Delirium; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Enkephalin, Methionine; Evoked Potentials, Somatosensory; Female; Heart Rate; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Postoperative Care; Propofol; Substance Withdrawal Syndrome; Sufentanil

2005

Other Studies

11 other study(ies) available for sufentanil and Substance Withdrawal Syndrome

ArticleYear
Postsurgery analgesic and sedative drug use in a French neonatal intensive care unit: A single-center retrospective cohort study.
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2019, Volume: 26, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Cohort Studies; Drug Utilization; Female; Fentanyl; France; Hospitals, University; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Midazolam; Morphine; Nalbuphine; Off-Label Use; Pain Measurement; Pain, Postoperative; Retrospective Studies; Substance Withdrawal Syndrome; Sufentanil; Urinary Retention

2019
Sufentanil and midazolam dosing and pharmacogenetic factors in pediatric analgosedation and withdrawal syndrome.
    Physiological research, 2016, 12-21, Volume: 65, Issue:Suppl 4

    Topics: Adjuvants, Anesthesia; Child; Dose-Response Relationship, Drug; Female; Genetic Variation; Humans; Infant; Infant, Newborn; Male; Midazolam; Pediatrics; Pharmacogenetics; Polymorphism, Single Nucleotide; Substance Withdrawal Syndrome; Sufentanil

2016
No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
    European journal of anaesthesiology, 2010, Volume: 27, Issue:2

    Topics: Afferent Pathways; Analgesics, Opioid; Animals; Blood Pressure; Bradycardia; Dogs; Dose-Response Relationship, Drug; Etorphine; Evoked Potentials, Somatosensory; Heart Rate; Hyperalgesia; Hypotension; Naloxone; Narcotic Antagonists; Piperidines; Remifentanil; Substance Withdrawal Syndrome; Sufentanil

2010
Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 340, Issue:1

    Topics: Adaptation, Physiological; Analgesics, Opioid; Animals; Blotting, Western; Cholera Toxin; Dose-Response Relationship, Drug; Endorphins; Female; Immunoprecipitation; Male; Morphine; Narcotic Antagonists; Oligopeptides; Perfusion; Pertussis Toxin; Protein Phosphatase 2; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sex Characteristics; Spine; Substance Withdrawal Syndrome; Sufentanil

2012
Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal.
    Addiction biology, 2005, Volume: 10, Issue:2

    Topics: Acute Disease; Animals; Biotransformation; Dogs; Evoked Potentials, Somatosensory; Naltrexone; Narcotics; Protein Kinase C; Receptors, Opioid; Somatoform Disorders; Substance Withdrawal Syndrome; Sufentanil

2005
Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.
    Neurochemical research, 1994, Volume: 19, Issue:10

    Topics: Animals; Brain; Cerebral Ventricles; Glucose; Infusions, Intravenous; Infusions, Parenteral; Male; Morphine Dependence; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Sufentanil

1994
Is morphine dependence mediated exclusively by the Mu receptor?
    Neurochemical research, 1993, Volume: 18, Issue:10

    Topics: Animals; Behavior, Animal; Brain; Glucose; Male; Morphine Dependence; Naloxone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Regression Analysis; Substance Withdrawal Syndrome; Sufentanil

1993
Epidural sufentanil for acute pain control in a patient with extreme opioid dependency.
    Anesthesiology, 1992, Volume: 76, Issue:5

    Topics: Adult; Analgesia, Epidural; Analgesics; Female; Fentanyl; Humans; Methadone; Pain, Postoperative; Postoperative Complications; Substance Withdrawal Syndrome; Sufentanil

1992
Parker and Radow test of drug withdrawal aversion: opposite effect in rats chronically infused with sufentanil or amphetamine.
    Pharmacology, biochemistry, and behavior, 1990, Volume: 35, Issue:1

    Topics: Analgesics, Opioid; Animals; Body Weight; Choice Behavior; Dextroamphetamine; Fentanyl; Infusion Pumps; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Sufentanil; Taste

1990
Tolerance to the respiratory actions of opiates: withdrawal tolerance and asymmetrical cross-tolerance.
    European journal of pharmacology, 1990, Jan-03, Volume: 175, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Drug Tolerance; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Fentanyl; Injections, Intravenous; Injections, Intraventricular; Injections, Subcutaneous; Male; Morphine; Narcotics; Rats; Rats, Inbred Strains; Respiratory System; Substance Withdrawal Syndrome; Sufentanil

1990
Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat.
    European journal of pharmacology, 1989, Aug-03, Volume: 166, Issue:3

    Topics: Animals; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Fentanyl; Injections, Spinal; Male; Morphine; Naloxone; Narcotics; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders; Sufentanil; Time Factors

1989